Concepedia

Veena S. John

VS

Statistics

Publications

9

Citations

890

H-Index

9

Active since

2010

Affiliations

Northwell Health(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Indiana University – Purdue University Indianapolis

Cleveland Clinic

Roswell Park Comprehensive Cancer Center

Veena S. John is an author at Northwell Health specializing in oncology, medicine, and cancer therapeutics.

Top concepts

Publications per year

2010–2025

9

Publications

9

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

Ramez N. Eskander, Michael W. Sill, Lindsey Beffa et al. · New England Journal of Medicine · 2023 · 626 citations · Full text

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

, , +9

Trastuzumab-DM1: A Clinical Update of the Novel Antibody-Drug Conjugate for HER2-Overexpressing Breast Cancer

Myra F. Barginear, Veena S. John, Daniel R. Budman · Molecular Medicine · 2012 · 59 citations · Full text

, , +17

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

Ramez N. Eskander, Michael W. Sill, Lindsey Beffa et al. · Nature Medicine · 2025 · 32 citations · Full text

, , +7

The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines

Daniel R. Budman, Julia Tai, Anthony Calabro et al. · Investigational New Drugs · 2010 · 26 citations

, , +7

1–5 of 9